Creutzfeldt-Jakob disease and advanced therapy medicinal products

Current version

PDF icon<b>Position statement</b>

Reference numberEMA/CHMP/CAT/BWP/353632/2010
Published28/06/2011
KeywordsCreutzfeldt-Jakob disease, gene therapy, cell therapy and tissue engineering medicinal products, donor selection criteria, tissue and blood donation
DescriptionThis document considers the risk of transmitting Creutzfeldt-Jakob disease (CJD) or variant CJD agents via the advanced therapy medicinal products.


Document history

First version

Current version

PDF iconPosition statement


PDF iconOverview of comments


PDF iconDraft position paper

Published: 28/06/2011


Published: 28/06/2011


Published: 27/07/2010


Related content


How useful was this page?

Add your rating